recap neg price
follow pg result updat guidanc announc acquisit
merck consum health busi lower
ep estim respect
encourag continu success sever pg busi
laundri beauti health believ littl visibl
price environ improv babi groom lower
price target ep line peer maintain
result street follow note publish
morn link earlier today pg report result includ better
expect sale ep vs consensu slight ep miss vs
estim net sale yoy estim
yoy consensu estim yoy
adjust ep estim
consensu estim total organ sale growth yoy
compani full-year target compani maintain
organ sale growth rang expect come
low end continu expect all-in sale growth addit
compani rais low end core ep growth rang expect
core ep growth vs previou rang
addit pg announc sign agreement
purchas merck consum health busi annual
revenu busi includ over-the-counter health care product
sold primarili europ latin america asia
takeaway form confer call key takeaway today
confer call includ
tr target
issu babi continu organ growth compani babi feminin famili segment
driven volum price pg comment issu market specif
taken longer anticip compani see improv
china saw first quarter posit diaper sale year diaper organ sale
premium tape pant innov actual well market issu
still declin mid-tier tape diaper segment declin pg portfolio
index addit babi busi us luv brand particular also see
pressur retail pursu privat label offer continu press manufactur
price area compani note see price almost seem
like compani take right step china timelin improv continu
push addit competit price us concern sure
improv sight
groom volum improv still competit pg note grown men volum
share us past four consecut quarter result price action compani
fulli lap action begin month expect strong volum shipment growth
translat stronger net sale growth go forward post men system growth
howev compani expect categori remain competit go forward note
will aggress defend posit specif valu tier competitor harri privat
enter nr near futur competitor move
dtc europ believ compani better posit groom portfolio
would expect promot activ remain elev order defend posit
merck deal compani provid detail announc acquisit
merck mrk-etr nr consum health busi name deal expect
close calendar year end neutral organ sale growth core ep
accret organ sale core ep start assum close dec
add sale annual sale term discontinu teva
jv compani expect sale segment hit full year
profit impact teva-tlv ila nr current compani report sale
jv segment report profit bottom line come
minor interest compani note jv use distribut
brand like vick europ compani use newli acquir merck suppli chain take
distribut
adjust estim maintain hold base result updat guidanc
lower ep respect overal
attribut neg price trend one primari driver stock declin today
vs cpg space remain highli competit retail push back price
emphas privat label offer encourag continu success
sever pg busi laundri beauti health believ littl visibl
price environ improv babi groom understand compani
activ look launch new premium innov effort drive price similar
saw pod laundri bead note wont idea success
effort mid earliest lower price target
ep line peer maintain hold
page
fabric
babi feminin famili
chang sale
sale
fabric
babi feminin famili
dollar million except per-shar data
sourc compani report suntrust robinson humphrey estim
price
page
procter gambl world-wide manufactur premium mid-tier consum product includ
billion-dollar brand particip market countri compani
manag busi five segment beauti groom health fabric
babi famili pg well known brand includ pamper tide panten alway
crest bounti gillett
believ pg focus busi post divestitur process hold rate
base belief price headwind wane investor appetit higher yield keep
stock trade rang come quarter addit continu see difficult macro
trend cpg space believ pressur top-lin growth forese futur
valuat risk
price target equat ep estim line cpg peer-group averag
upsid risk rate price target includ higher growth profit
china busi accret share repurchas downsid risk rate price
activ core categori signific currenc fluctuat
compani mention note
william chappel jr herebi certifi view express research report accur
reflect person view subject compani secur also certifi
receiv direct indirect compens exchang
express specif recommend report
